FindTrial
Sign In

A Single-Center, Comparative Clinical Study: Evaluation of CCK8 Technology in Bacterial and Drug Sensitivity Testing for Diabetic Foot Wounds

A Single-Center, Comparative Clinical Study: Evaluation of CCK8 Technology in Bacterial and Drug Sensitivity Testing for Diabetic Foot Wounds

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108406
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcers

Interventions

Gold Standard:Traditional bacterial culture and drug sensitivity testing method
Index test:A new antibiotic sensitivity testing method (CCK8 method)

Sponsors

Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with T2DM meeting the WHO 1999 diagnostic criteria; 2. Diagnosed with diabetic foot infection (DFI); 3. Aged 18 to 70 years (inclusive).

Exclusion criteria

Exclusion criteria: 1. Patients with diabetic ketoacidosis (DKA) or hyperosmolar state; 2. Patients with lower limb large artery occlusion or ankle-brachial index (ABI) < 0.60; 3. Patients with severe coronary heart disease, cerebral infarction, heart failure, or renal failure; 4. Patients with malignant tumors; 5. Patients using immunosuppressants; 6. Pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
Antibiotic sensitivity;Bacterial species;Accuracy;Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactShao Shiying

Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

shaoshiyingtj@163.com+86 136 2714 4576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026